China Health Industries Holdings, Inc. (CHHE) Receivables (2016 - 2023)
China Health Industries Holdings (CHHE) has disclosed Receivables for 13 consecutive years, with $38257.0 as the latest value for Q1 2023.
- For the quarter ending Q1 2023, Receivables fell 62.04% year-over-year to $38257.0, compared with a TTM value of $38257.0 through Mar 2023, down 62.04%, and an annual FY2022 reading of $41345.0, down 98.26% over the prior year.
- Receivables was $38257.0 for Q1 2023 at China Health Industries Holdings, down from $39463.0 in the prior quarter.
- Across five years, Receivables topped out at $5.6 million in Q4 2020 and bottomed at $37669.0 in Q3 2022.
- Average Receivables over 5 years is $2.1 million, with a median of $2.0 million recorded in 2019.
- The sharpest move saw Receivables soared 147.96% in 2020, then plummeted 98.53% in 2021.
- Year by year, Receivables stood at $3.3 million in 2019, then soared by 70.35% to $5.6 million in 2020, then tumbled by 98.53% to $82062.0 in 2021, then plummeted by 51.91% to $39463.0 in 2022, then dropped by 3.06% to $38257.0 in 2023.
- Business Quant data shows Receivables for CHHE at $38257.0 in Q1 2023, $39463.0 in Q4 2022, and $37669.0 in Q3 2022.